$4.70 0.04 (+0.86%)
2/9/2010 4:00 PM

Idera Pharmaceuticals, Inc. (IDRA)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants.

Current Price $4.70 Mkt Cap $110.31M
Open $4.74 P/E Ratio 27.41
Prev. Close $4.66 Div. (Yield) N/A (N/A)
Daily Range $4.64 - $4.77 Volume 19,037
52-Wk Range $4.48 - $8.50 Avg. Daily Vol. 0

Related News and Articles

Caps

How do you think IDRA will perform vs the S&P 500?

Add Stock to Watchlist

All Members

53 Outperform
12 Underperform
 

All-Star Members

10 Outperform
5 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top IDRA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

lemapud (< 20)
Submitted January 22, 2007

IDERA has cutting edge new science in the field of immunology. They have had their share of followers and detractors over the years, and survived through it all. They have a strong company plan now, good partners, and exciting therapies that will be… More

zzlangerhans (99.64)
Submitted March 18, 2009

In October the lead compound IMO2055 failed a phase II trial for renal cell carcinoma. What kept the stock from tanking more than 25% on the bad news, considering that the whole pipeline consists of related TLR9 agonists and antagonists? Probably the… More

IDRA VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about IDRA.

Recs

0
Member Avatar zzlangerhans (99.64) Submitted: 11/18/2009 9:58:41 AM : Outperform Start Price: $5.12 IDRA Score: -5.47

Rather than an endorsement of Idera's pipeline, this green thumb represents confidence in their low burn and the volatility of the stock. Having stabilized off a recent spike and plunge (for no discernible reason), Idera is primed to reascend and has all the time in the world to get there.

Recs

0
Member Avatar ScreenerStizBear (< 20) Submitted: 6/26/2008 2:26:22 PM : Underperform Start Price: $14.63 IDRA Score: +53.90

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

Recs

0
Member Avatar goldnrtrvrlvr (< 20) Submitted: 5/5/2008 7:24:39 AM : Outperform Start Price: $14.75 IDRA Score: -47.23

New Hi

Leaderboard

Find the members with the highest scoring picks in IDRA.

Score Leader

schwah8

schwah8 (99.46) Score: +72.68

The Score Leader is the member with the highest score across all their picks in IDRA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
schwah8 99.46 10/13/2008 Underperform NS $10.65 -56.06% +16.62% +72.68
qubit15 20.00 1/21/2009 Underperform NS $7.45 -37.18% +34.01% +71.20
ScreenerStizBear < 20 6/26/2008 Underperform NS $14.63 -68.01% -14.11% +53.90 1 Comment
seanleckey 99.71 7/7/2008 Underperform 5Y $13.03 -64.08% -12.62% +51.46
Reboshua < 20 4/22/2009 Underperform NS $5.96 -21.48% +28.68% +50.16
anticitradeshort 21.60 4/20/2009 Underperform NS $6.09 -23.15% +26.85% +50.00
mbeleza < 20 11/14/2007 Underperform 1Y $12.15 -61.48% -24.60% +36.88 1 Comment
eXigy 98.89 9/5/2007 Underperform 1Y $8.80 -46.82% -23.36% +23.46 1 Comment
MRTShorts 99.10 10/8/2007 Underperform NS $9.28 -49.57% -27.59% +21.98
TheWINingest < 20 6/4/2007 Underperform 5Y $8.05 -41.86% -26.06% +15.81

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackNobleFinanc 88.22 11/21/2008 Outperform NS $5.98 -21.74% +44.55% -66.29
TrackSusquehanna 74.51 5/2/2008 Underperform NS $14.20 -28.73% -38.31% -9.58 10/27/2008 @ $10.12
TrackMDB < 20 5/22/2007 Outperform NS $8.74 -46.45% -25.62% -20.83
TrackJanney 74.31 4/18/2007 Outperform NS $8.98 +64.03% -4.22% +68.25 5/7/2008 @ $14.73
TrackMerriman < 20 2/7/2007 Outperform NS $9.45 -50.48% -21.46% -29.02

Featured Broker Partners